Pathophysiology and management of glaucoma and ocular hypertension related to trauma.
Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS.
Surv Ophthalmol. 2020 Sep-Oct;65(5):530-547. doi: 10.1016/j.survophthal.2020.02.003. Epub 2020 Feb 11.
OCULAR HYPERTENSION AND GLAUCOMA FOLLOWING VITRECTOMY: A Systematic Review.
Miele A, Govetto A, Fumagalli C, Donati S, Biagini I, Azzolini C, Rizzo S, Virgili G.
Retina. 2018 May;38(5):883-890. doi: 10.1097/IAE.0000000000001651.
Uveitic Ocular Hypertension and Glaucoma.
Cunningham ET Jr, Zierhut M.
Ocul Immunol Inflamm. 2017 Dec;25(6):737-739. doi: 10.1080/09273948.2017.1415077.
Ocular hypertension.
Gopal KS.
Indian J Ophthalmol. 2004 Sep;52(3):257-8; author reply 258-9.
Viral Vector-Induced Ocular Hypertension in Mice.
Millar JC, Sundaresan Y, Zode GS, Clark AF.
Methods Mol Biol. 2023;2708:77-97. doi: 10.1007/978-1-0716-3409-7_9.
Current management of uveitis-associated ocular hypertension and glaucoma.
Kesav N, Palestine AG, Kahook MY, Pantcheva MB.
Surv Ophthalmol. 2020 Jul-Aug;65(4):397-407. doi: 10.1016/j.survophthal.2019.12.003. Epub 2019 Dec 6.
Glucocorticoid therapy and ocular hypertension.
Dibas A, Yorio T.
Eur J Pharmacol. 2016 Sep 15;787:57-71. doi: 10.1016/j.ejphar.2016.06.018. Epub 2016 Jul 5.
Current intravitreal therapy and ocular hypertension: A review.
Sudhalkar A, Bilgic A, Vasavada S, Kodjikian L, Mathis T, de Ribot FM, Papakostas T, Vasavada V, Vasavada V, Srivastava S, Bhojwani D, Ghia P, Sudhalkar A.
Indian J Ophthalmol. 2021 Feb;69(2):236-243. doi: 10.4103/ijo.IJO_1028_20.
Metabolic Syndrome Is Associated With Ocular Hypertension and Glaucoma.
Roddy GW.
J Glaucoma. 2020 Sep;29(9):726-731. doi: 10.1097/IJG.0000000000001593.
Ocular Hypertension Treatment Study (OHTS) commentary.
Lee BL, Wilson MR; Ocular Hypertension Treatment Study (OHTS).
Curr Opin Ophthalmol. 2003 Apr;14(2):74-7. doi: 10.1097/00055735-200304000-00003.
